Open AccessGLUCOSE METABOLISM AFTER PANCREAS TRANSPLANTATION: CYCLOSPORINE VERSUS TACROLIMUS
Author(s) -
C. Dieterle,
Susanne Schmauss,
M. Veitenhansl,
B. Gutt,
WolfDieter Illner,
W. Land,
Rüdiger Landgraf
Publication year - 2004
Publication title -
transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000129063.65446.65
Subject(s) - tacrolimus , transplantation , medicine , immunosuppression , endocrinology , pancreas transplantation , diabetes mellitus , insulin , islet , basal (medicine) , gastroenterology , kidney transplantation , urology
The results of the new immunosuppressants in simultaneous pancreas-kidney transplantation (SPK) concerning organ survival and rejection rates are excellent. Tacrolimus as well as cyclosporine are assumed to be diabetogenic; however, there are no comparative studies investigating their effects on glucose metabolism.